Canada markets closed

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
49.55+2.33 (+4.93%)
At close: 04:00PM EDT
49.55 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.58B
Enterprise Value 1.96B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)160.48
Price/Book (mrq)3.93
Enterprise Value/Revenue 129.72
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 3.54
52-Week Change 3476.16%
S&P500 52-Week Change 332.96%
52 Week High 365.60
52 Week Low 35.65
50-Day Moving Average 344.26
200-Day Moving Average 337.57

Share Statistics

Avg Vol (3 month) 3563.75k
Avg Vol (10 day) 3598.64k
Shares Outstanding 552.16M
Implied Shares Outstanding 652.16M
Float 832.41M
% Held by Insiders 19.27%
% Held by Institutions 198.07%
Shares Short (Sept 30, 2024) 43.46M
Short Ratio (Sept 30, 2024) 45.45
Short % of Float (Sept 30, 2024) 413.11%
Short % of Shares Outstanding (Sept 30, 2024) 46.63%
Shares Short (prior month Aug 30, 2024) 43.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -291.17%
Operating Margin (ttm)-155.36%

Management Effectiveness

Return on Assets (ttm)-7.98%
Return on Equity (ttm)-9.20%

Income Statement

Revenue (ttm)15.13M
Revenue Per Share (ttm)0.31
Quarterly Revenue Growth (yoy)741.70%
Gross Profit (ttm)N/A
EBITDA -63.86M
Net Income Avi to Common (ttm)-44.05M
Diluted EPS (ttm)-0.88
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)646.29M
Total Cash Per Share (mrq)12.39
Total Debt (mrq)23.82M
Total Debt/Equity (mrq)3.62%
Current Ratio (mrq)57.34
Book Value Per Share (mrq)12.61

Cash Flow Statement

Operating Cash Flow (ttm)-46.47M
Levered Free Cash Flow (ttm)-36.22M